Eugene Frederick Leffler III - 12 Jul 2024 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Source evidence 5 source fields
Form type
4
Accepted by SEC
16 Jul 2024, 19:52:11 UTC
Previous filing
12 Jan 2023
Next filing
16 Sep 2025
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III

Key filing fact

Eugene Frederick Leffler III filed Form 4 for Biofrontera Inc. (BFRI) on 16 Jul 2024.

Key facts

  • This page summarizes Eugene Frederick Leffler III's Form 4 filing for Biofrontera Inc. (BFRI).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 16 Jul 2024, 19:52.

Change

  • Previous filing in this sequence was filed on 12 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFRI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+175,000
Change %
Price
$0.000000
Shares after
175,000
Date
12 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
175,000
Exercise price
Footnotes
F1, F2
BFRI transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
$0
Shares
+175,000
Change %
+3500%
Price
$0.000000
Shares after
180,000
Date
12 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
175,000
Exercise price
$1.38
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of BFRI common stock. The reporting person received the restricted stock units as an award for no consideration.

Footnote F2

The restricted stock units vest over one year in two equal installments, the first of which will be on the six month anniversary of the grant date and the second of which will be on the one-year anniversary of the grant date. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

Footnote F3

The option vests in three virtually equal annual installments beginning on July 12, 2025.

SEC remarks

All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .